Home Research Effects of GLP-1 Receptor Agonists and Dual GIP/GLP-1… Effects of GLP-1 Receptor Agonists and Dual GIP/GLP-1 Receptor Agonists on Inflammatory and Metabolic Biomarkers in Type 2 Diabetes: A Systematic Review and Meta-Analysis Meta-analysis published in Diabetes, obesity & metabolism (2026) covering Tirzepatide.
Meta-analysis.
The record Journal: Diabetes, obesity & metabolism 28(10): 9002-9013 Published: 2026-07-14 PMID: 42449480 — DOI: 10.1111/dom.71106 MeSH terms: Humans, Diabetes Mellitus, Type 2, Inflammation, Malondialdehyde, Gastric Inhibitory Polypeptide, Tumor Necrosis Factor-alpha, C-Reactive Protein, Interleukin-6, Hypoglycemic Agents, Oxidative Stress, Adiponectin, Chemokine CCL2, Randomized Controlled Trials as Topic, Biomarkers, Glucagon-Like Peptide-1 Receptor Agonists Author countries: Italy, Romania, Turkey, USA Peptide profiles: Tirzepatide .
All indexed evidence: Tirzepatide trials & papers .
Related studies: Peripheral nerve complications from medications utilised for weight loss: a systematic… , Incretin-Based Therapies in Doxorubicin-Induced Cardiotoxicity: A Systematic Review of… , Comparative effects of drugs for adults with overweight or obesity: systematic review… , Cardiovascular Outcomes With Tirzepatide Versus GLP-1 Receptor Agonists in Overweight or… .